These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 4995695)

  • 1. A double-blind study of an oxazepam hemisuccinate-hexadiphane combination in management of gastrointestinal disorders.
    Strumia E; Babbini M
    Curr Ther Res Clin Exp; 1971 Apr; 13(4):251-6. PubMed ID: 4995695
    [No Abstract]   [Full Text] [Related]  

  • 2. [Double-blind evaluation of a combined oxazepam hemisuccinate-hexadiphane treatment versus hexadiphane in the therapy of visceral spastic syndromes].
    Palmas F; Babbini M
    Minerva Gastroenterol; 1972; 18(1):27-34. PubMed ID: 4614108
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical studies of GE 1783].
    Greif S; Stampfer E
    Wien Med Wochenschr; 1972 Sep; 122(40):568-70. PubMed ID: 4562563
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of functional digestive disorders with a drug composed of a neuroleptic and an anticholinergic agent].
    Cachin M; Roge J; Pergola F; Levy C
    Presse Med (1893); 1971 Mar; 79(13):585-6. PubMed ID: 5553539
    [No Abstract]   [Full Text] [Related]  

  • 5. Double-blind study of a psychotropic-anticholinergic drug in gastric disorders.
    Cromwell HA
    Med Times; 1968 Sep; 96(9):933-8. PubMed ID: 4876840
    [No Abstract]   [Full Text] [Related]  

  • 6. Trazodone and psychosomatic medicine.
    Knobel M
    Curr Ther Res Clin Exp; 1973 Oct; 15(10):789-98. PubMed ID: 4201977
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anticholinergic and benzodiazepine drugs in the therapy of functional colonic diseases].
    Del Vecchio-Blanco C; Stroffolini T
    Minerva Dietol Gastroenterol; 1981; 27(4):593-8. PubMed ID: 7038544
    [No Abstract]   [Full Text] [Related]  

  • 8. Antalgic properties of proxazole. Double blind study in visceral algoplastic conditions.
    De Gregorio M; Damiani S; Gatta G
    Panminerva Med; 1969 Sep; 11(9):436-40. PubMed ID: 4901029
    [No Abstract]   [Full Text] [Related]  

  • 9. [The association of lexotan + propantheline in the treatment of functional gastrointestinal disorders. Controlled clinical study].
    Riva D; Manieri L; Mariano P
    Arch Sci Med (Torino); 1980; 137(3):461-6. PubMed ID: 6112973
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of functional abdominal distress. Double-blind test with Buscopan and Tranquo-Buscopan].
    Neiger A; Bircher J
    Schweiz Med Wochenschr; 1970 Jul; 100(28):1237-40. PubMed ID: 4935585
    [No Abstract]   [Full Text] [Related]  

  • 11. [DA 3177 a new synthetic spasmolytic agent in the management of spastic-dyskinetic conditions of the digestive tract. Double-blind controlled clinical trial].
    Bonzi G; Reguzzoni G; Rocca F; Negri L
    Clin Ter; 1979 Apr; 89(2):187-96. PubMed ID: 385213
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical experimentation with pentanobornamide, a new synthetic spasmolytic].
    Miracco A; Peluso C
    Clin Ter; 1970 Mar; 52(6):557-63. PubMed ID: 4916457
    [No Abstract]   [Full Text] [Related]  

  • 13. [Place of tranquilizer therapy in digestive tract pathology: study of oxazepam].
    Hallacq A
    Lyon Med; 1969 Sep; 222(31):251-4. PubMed ID: 5398814
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of the methylperidol-hexadiphane combination in an intensive care unit for coronary patients].
    Jausseran JM; Sivan J; Liberge F; Picard JP; Torresani J; Jouve A
    Mars Med; 1970; 107(11):945-8. PubMed ID: 5488519
    [No Abstract]   [Full Text] [Related]  

  • 15. [Flupentixol (Fluanxol) or diazepam in the treatment of various psychosomatic conditions. A controlled double-blind multicenter study].
    Damsbo N; Lassen T; Falhof SL
    Ugeskr Laeger; 1986 Dec; 149(1):12-6. PubMed ID: 3544417
    [No Abstract]   [Full Text] [Related]  

  • 16. [Gefarnax in the treatment of gastrointestinal diseases of psychosomatic origin].
    Bianchi A; Scanni A; Giorgi-Conciato M
    Minerva Gastroenterol; 1972; 18(3):175-81. PubMed ID: 4614115
    [No Abstract]   [Full Text] [Related]  

  • 17. [Double-blind controlled trial on treatment of psychosomatic syndromes by a new tranquilizer combination].
    Mereto GC
    Minerva Med; 1974 Mar; 65(17):923-35. PubMed ID: 4596804
    [No Abstract]   [Full Text] [Related]  

  • 18. A double-blind cross-over evaluation of the activity of d-oxazepam hemisuccinate sodium salt (D-7-chloro-1,3-dihydro-3-hemisuccinyloxy-5-phenyl-2H-1,4-benzodiazepine-2-one) compared to its racemic form.
    Lescovelli M; Castellani A; Perbellini D
    Arzneimittelforschung; 1976; 26(8):1623-6. PubMed ID: 795440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of functional and emotional symptoms in patients with gastrointestinal disorders.
    Fisher JW
    Curr Ther Res Clin Exp; 1969 May; 11(5):247-51. PubMed ID: 4977394
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experiences with adumbran in severe mental stress situations].
    Faris WF
    Dtsch Med J; 1968 Sep; 19(17):607-11. PubMed ID: 5702739
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.